Workflow
Contact
Revolutionizing Drug Discovery Through AI-Powered Antibody Intelligence
Transforming antibody therapeutics with our AI platform trained on real-world data, targeting neurology, infectious diseases, and oncology.
Our Technology Platform
Our proprietary AI model analyzes vast datasets of antibody sequences and their corresponding affinities.
We integrate real-world biological data with advanced machine learning algorithms to predict critical antibody properties.
This unique approach streamlines candidate selection, dramatically reducing discovery timelines.
How It Works
Data Integration
We collect massive datasets of antibody sequences linked to real-world binding affinity measurements.
AI Prediction
Our models predict antibody properties like specificity, affinity, stability, and manufacturability.
Candidate Selection
Algorithms identify promising candidates before expensive lab testing begins.
Accelerated Development
Validated candidates move quickly to optimization and clinical development.
Our Experimental Workflow
Immunization
Target antigens are used to stimulate immune responses in humanized models, generating diverse antibody repertoires against specific disease targets.
Single B Cell Isolation
Individual B cells that produce antibodies with desired binding properties are isolated using high-throughput fluorescence-activated cell sorting.
Next-Generation Sequencing
Isolated B cells undergo deep sequencing to identify unique antibody gene sequences with exceptional precision and coverage.
BCR Sequence & Affinity Analysis
Comprehensive analysis correlates B cell receptor sequences with binding affinities, enriching our AI platform with real-world biological data.
Disease Focus Areas
Neurology
Targeting complex neurodegenerative disorders with precision antibodies that cross the blood-brain barrier.
Infectious Diseases
Developing neutralizing antibodies against emerging viral and bacterial pathogens with pandemic potential.
Oncology
Creating targeted immunotherapies that precisely engage cancer cells while sparing healthy tissue.
Our Vision
We envision a world where antibody therapeutics are developed in months, not years, delivering transformative treatments to patients faster than ever before.
Revolutionize the speed and precision of antibody drug discovery through AI-driven insights.
Bridge computational innovation with biological reality to address unmet medical needs.
Deliver safer, more effective antibody therapies to patients worldwide.
About Us
Founded by experts in computational biology, AI engineering, and antibody development with decades of combined experience.
Scientific Rigor
All discoveries validated through strict experimental protocols and peer review.
Collaboration
Working with global academic and industry partners to advance therapeutic innovation.
Patient Impact
Every decision guided by our mission to improve patient outcomes worldwide.
Contact Us
Get in Touch
Email: info@shafaai.io
Phone: +1 (650) 273-7411‪
Address: 1030 Brittan Ave. San Carlos, CA 94070
Follow us on LinkedIn and Twitter for the latest updates on our platform and pipeline developments.